References

Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron

10.1002/ajh.23376 · ExternalCitation · doi-reference

Interscanner reproducibility of cardiovascular magnetic resonance T2∗ measurements of tissue iron in thalassemia

10.1002/jmri.10396 · ExternalCitation · doi-reference

Left ventricular diastolic function compared with T2∗ cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major

10.1002/jmri.20379 · ExternalCitation · doi-reference

Improved R2∗ measurements in myocardial iron overload

10.1002/jmri.20467 · ExternalCitation · doi-reference

Multislice multiecho T2∗ cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload

10.1002/jmri.20566 · ExternalCitation · doi-reference

R2∗ imaging of transfusional iron burden at 3T and comparison with 1.5T

10.1002/jmri.20816 · ExternalCitation · doi-reference

Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron

10.1002/jmri.20915 · ExternalCitation · doi-reference

Black-blood T2∗ technique for myocardial iron measurement in thalassemia

10.1002/jmri.20929 · ExternalCitation · doi-reference

Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart

10.1002/jmri.21119 · ExternalCitation · doi-reference

International reproducibility of single breathhold T2∗ MR for cardiac and liver iron assessment among five thalassemia centers

10.1002/jmri.22245 · ExternalCitation · doi-reference

Automated truncation method for myocardial T2∗ measurement in thalassemia

10.1002/jmri.23780 · ExternalCitation · doi-reference

Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload

10.1002/jmri.24727 · ExternalCitation · doi-reference

Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart

10.1002/mrm.20110 · ExternalCitation · doi-reference

MRI detects myocardial iron in the human heart

10.1002/mrm.20981 · ExternalCitation · doi-reference

Feasibility, reproducibility, and reliability for the T∗2 iron evaluation at 3 T in comparison with 1.5 T

10.1002/mrm.23236 · ExternalCitation · doi-reference

Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping

10.1002/mrm.24878 · ExternalCitation · doi-reference

Multislice multiecho T2∗ cardiac magnetic resonance for the detection of heterogeneous myocardial iron distribution in thalassaemia patients

10.1002/nbm.1382 · ExternalCitation · doi-reference

Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: a randomized double-blind placebo-controlled trial

10.1002/pbc.29564 · ExternalCitation · doi-reference

Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum

10.1006/taap.1995.1008 · ExternalCitation · doi-reference

A systems biology approach to iron metabolism

10.1007/978-1-4939-2095-2_10 · ExternalCitation · doi-reference

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy

10.1007/s00109-005-0029-x · ExternalCitation · doi-reference

Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia

10.1007/s00246-007-9107-x · ExternalCitation · doi-reference

Left and right ventricular function and volume assessment in young thalassemia major patients with no related myocardial iron overload

10.1007/s00277-012-1543-x · ExternalCitation · doi-reference

Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients

10.1007/s00277-013-1876-0 · ExternalCitation · doi-reference

Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications

10.1007/s00277-020-04196-y · ExternalCitation · doi-reference

Intercentre reproducibility of magnetic resonance T2∗ measurements of myocardial iron in thalassaemia

10.1007/s10554-005-0651-2 · ExternalCitation · doi-reference

Iron in the heart. Etiology and clinical significance

10.1016/0002-9343(71)90240-3 · ExternalCitation · doi-reference

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major

10.1016/j.ahj.2009.10.025 · ExternalCitation · doi-reference

Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial

10.1016/j.amjmed.2013.05.002 · ExternalCitation · doi-reference

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian society for thalassemia and hemoglobinopathies

10.1016/j.bcmd.2009.01.002 · ExternalCitation · doi-reference

Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications

10.1016/j.bcmd.2011.03.007 · ExternalCitation · doi-reference

Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major

10.1016/j.bcmd.2012.09.002 · ExternalCitation · doi-reference

Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment

10.1016/j.cardfail.2010.05.009 · ExternalCitation · doi-reference

Cardiac iron overload evaluation in thalassaemic patients using T2∗ magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study

10.1016/j.htct.2021.01.014 · ExternalCitation · doi-reference

Detection of cardiac iron overload with native magnetic resonance T1 and T2 mapping in patients with thalassemia

10.1016/j.ijcard.2017.06.100 · ExternalCitation · doi-reference

Magnetic resonance in transthyretin cardiac amyloidosis

10.1016/j.jacc.2017.05.053 · ExternalCitation · doi-reference

Native T1 and ECV of noninfarcted myocardium and outcome in patients with coronary artery disease

10.1016/j.jacc.2017.12.020 · ExternalCitation · doi-reference

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis

10.1016/j.jcmg.2012.11.013 · ExternalCitation · doi-reference

Assessment of cardiac iron overload in thalassemia with MRI on 3.0-T: high-field T1, T2, and T2∗ quantitative parametric mapping in comparison to T2∗ on 1.5-T

10.1016/j.jcmg.2018.08.032 · ExternalCitation · doi-reference

Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone

10.1016/j.trsl.2010.05.002 · ExternalCitation · doi-reference

Exercise capacity in patients with beta-thalassemia major: relation to left ventricular and atrial size and function

10.1016/s0002-8703(98)70154-1 · ExternalCitation · doi-reference

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy

10.1016/s0002-9149(02)02381-0 · ExternalCitation · doi-reference

Heart failure in beta thalassemia: a 5-year follow-up study

10.1016/s0002-9343(01)00879-8 · ExternalCitation · doi-reference

Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients

10.1016/s0090-9556(25)07467-7 · ExternalCitation · doi-reference

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

10.1016/s0140-6736(02)09740-4 · ExternalCitation · doi-reference

Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload

10.1016/s0195-668x(02)00381-0 · ExternalCitation · doi-reference

Optimizing iron chelation strategies in beta-thalassaemia major

10.1016/s0268-960x(09)70003-7 · ExternalCitation · doi-reference

Iron overload in non-transfusion-dependent thalassemia: a clinical perspective

10.1016/s0268-960x(12)70006-1 · ExternalCitation · doi-reference

Molecular bases of cellular iron toxicity

10.1016/s0891-5849(02)00772-4 · ExternalCitation · doi-reference

Typical manifestation of acute congestive heart failure in patients with Thalassaemia major causing diagnostic delay in the emergency room

10.1016/s1388-9842(03)00102-8 · ExternalCitation · doi-reference

Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation

10.1034/j.1600-0609.2003.00075.x · ExternalCitation · doi-reference

Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1

10.1038/nm1542 · ExternalCitation · doi-reference

Combined therapy with deferiprone and desferrioxamine

10.1046/j.1365-2141.1998.01002.x · ExternalCitation · doi-reference

Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major

10.1046/j.1365-2141.2000.02298.x · ExternalCitation · doi-reference

Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

10.1046/j.1365-2141.2003.04240.x · ExternalCitation · doi-reference

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

10.1053/euhj.2000.2011 · ExternalCitation · doi-reference

Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload

10.1053/euhj.2001.2822 · ExternalCitation · doi-reference

Diagnostic value of T1 mapping in detecting iron overload in Indian patients with thalassemia major: a comparison with T2∗ mapping

10.1055/s-0043-1772467 · ExternalCitation · doi-reference

Survival in medically treated patients with homozygous beta-thalassemia

10.1056/nejm199409013310903 · ExternalCitation · doi-reference

Disorders of iron metabolism

10.1056/nejm199912233412607 · ExternalCitation · doi-reference

Iron-chelating therapy for transfusional iron overload

10.1056/nejmct1004810 · ExternalCitation · doi-reference

Time saving in measurement of NMR and EPR relaxation times

10.1063/1.1684482 · ExternalCitation · doi-reference

Exploring the “iron shuttle” hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture

10.1067/mlc.2001.116487 · ExternalCitation · doi-reference

Standardized T2∗ map of a normal human heart to correct T2∗ segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients

10.1080/03630260701879514 · ExternalCitation · doi-reference

Left ventricular diastolic dysfunction in beta-thalassemia major with heart failure

10.1080/03630269.2018.1451341 · ExternalCitation · doi-reference

Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance

10.1080/10976640600572889 · ExternalCitation · doi-reference

Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors

10.1086/515025 · ExternalCitation · doi-reference

Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium

10.1093/cvr/14.12.719 · ExternalCitation · doi-reference

Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study

10.1093/ehjqcco/qcab089 · ExternalCitation · doi-reference

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

10.1093/ejechocard/jep007 · ExternalCitation · doi-reference

Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance

10.1093/eurheartj/ehl336 · ExternalCitation · doi-reference

Relation of myocardial T2∗ to right ventricular function in thalassaemia major

10.1093/eurheartj/ehq106 · ExternalCitation · doi-reference

Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology

10.1093/eurheartj/ehq474 · ExternalCitation · doi-reference

T1 mapping and survival in systemic light-chain amyloidosis

10.1093/eurheartj/ehu444 · ExternalCitation · doi-reference

Cardiac mortality in beta-thalassemia major: resting but not dobutamine stress echocardiography predicts mortality among initially cardiac disease-free patients in a prospective 12-year study

10.1093/eurjhf/hfp152 · ExternalCitation · doi-reference

2021 Thalassaemia international federation guidelines for the management of transfusion-dependent thalassemia

10.1097/hs9.0000000000000732 · ExternalCitation · doi-reference

Burden of cardiac siderosis in a thalassemia-major endemic population: a preliminary report from Pakistan

10.1097/mph.0000000000000574 · ExternalCitation · doi-reference

Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2 years

10.1097/mph.0b013e3181e015b0 · ExternalCitation · doi-reference

10.1111/anec.12389

10.1111/anec.12389 · ExternalCitation · doi-reference

Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias

10.1111/bjh.17839 · ExternalCitation · doi-reference

Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients

10.1111/ejh.12507 · ExternalCitation · doi-reference

Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload

10.1111/j.1365-2141.1995.tb03318.x · ExternalCitation · doi-reference

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2∗ cardiovascular magnetic resonance

10.1111/j.1365-2141.2004.05202.x · ExternalCitation · doi-reference

Severe infections in thalassaemic patients: prevalence and predisposing factors

10.1111/j.1365-2141.2006.06082.x · ExternalCitation · doi-reference

Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major

10.1111/j.1365-2141.2008.07092.x · ExternalCitation · doi-reference

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

10.1111/j.1365-2141.2009.07970.x · ExternalCitation · doi-reference

Sickle-cell disease and the heart: review of the current literature

10.1111/j.1365-2141.2012.09143.x · ExternalCitation · doi-reference

Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias

10.1111/j.1445-5994.2011.02527.x · ExternalCitation · doi-reference

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review

10.1111/j.1537-2995.2007.01416.x · ExternalCitation · doi-reference

Right ventricular function in patients with beta thalassemia: relation to serum ferritin level

10.1111/j.1540-8175.2007.00480.x · ExternalCitation · doi-reference

Detection of early cardiac dysfunction in patients with Beta thalassemia by tissue Doppler echocardiography

10.1111/j.1540-8175.2010.01270.x · ExternalCitation · doi-reference

Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2

10.1111/j.1600-0609.2005.00587.x · ExternalCitation · doi-reference

T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice

10.1111/j.1600-0609.2010.01549.x · ExternalCitation · doi-reference

Cardiac involvement in Cooley’s anemia

10.1111/j.1749-6632.1965.tb54070.x · ExternalCitation · doi-reference

Pathogenesis and management of iron toxicity in thalassemia

10.1111/j.1749-6632.2010.05544.x · ExternalCitation · doi-reference

Unexpected myocarditis in thalassaemia major patient screened for iron load cardiomyopathy

10.1136/bcr.08.2008.0811 · ExternalCitation · doi-reference

Survival and desferrioxamine in thalassaemia major

10.1136/bmj.284.6322.1081 · ExternalCitation · doi-reference

Human non-contrast T1 values and correlation with histology in diffuse fibrosis

10.1136/heartjnl-2012-303052 · ExternalCitation · doi-reference

Joint British society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices

10.1136/heartjnl-2022-320810 · ExternalCitation · doi-reference

Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

10.1136/hrt.2008.156497 · ExternalCitation · doi-reference

Iron chelators in treatment of iron overload

10.1155/2022/4911205 · ExternalCitation · doi-reference

Arterial stiffness and endothelial function in patients with beta-thalassemia major

10.1161/01.cir.0000037225.92759.a7 · ExternalCitation · doi-reference

Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis

10.1161/01.cir.30.5.698 · ExternalCitation · doi-reference

Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American heart association

10.1161/cir.0b013e31829b2be6 · ExternalCitation · doi-reference

Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping

10.1161/circimaging.112.000070 · ExternalCitation · doi-reference

Cardiac iron determines cardiac T2∗, T2, and T1 in the gerbil model of iron cardiomyopathy

10.1161/circulationaha.104.504415 · ExternalCitation · doi-reference

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

10.1161/circulationaha.106.648790 · ExternalCitation · doi-reference

Cardiac T2∗ magnetic resonance for prediction of cardiac complications in thalassemia major

10.1161/circulationaha.109.874487 · ExternalCitation · doi-reference

On T2∗ magnetic resonance and cardiac iron

10.1161/circulationaha.110.007641 · ExternalCitation · doi-reference

Ultrafast magnetic resonance imaging for iron quantification in thalassemia participants in the developing world: the TIC-TOC study (Thailand and UK international collaboration in thalassaemia optimising ultrafast CMR)

10.1161/circulationaha.116.022803 · ExternalCitation · doi-reference

Determination of iron in cardiac and liver tissues by plasma emission spectroscopy

10.1177/000456328702400510 · ExternalCitation · doi-reference

Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major

10.1182/blood-2003-08-2841 · ExternalCitation · doi-reference

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

10.1182/blood-2005-07-2933 · ExternalCitation · doi-reference

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

10.1182/blood-2005-07-2948 · ExternalCitation · doi-reference

Longitudinal analysis of heart and liver iron in thalassemia major

10.1182/blood-2008-04-148767 · ExternalCitation · doi-reference

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

10.1182/blood-2009-04-217455 · ExternalCitation · doi-reference

How I treat thalassemia

10.1182/blood-2010-08-300335 · ExternalCitation · doi-reference

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

10.1182/blood-2014-07-586677 · ExternalCitation · doi-reference

Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells

10.1182/blood.v83.9.2692.bloodjournal8392692 · ExternalCitation · doi-reference

Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia

10.1182/blood.v95.4.1229.004k32_1229_1236 · ExternalCitation · doi-reference

Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM)

10.1186/1476-7120-5-24 · ExternalCitation · doi-reference

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction

10.1186/1532-429x-10-12 · ExternalCitation · doi-reference

Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols

10.1186/1532-429x-10-35 · ExternalCitation · doi-reference

Improved survival of thalassaemia major in the UK and relation to T2∗ cardiovascular magnetic resonance

10.1186/1532-429x-10-42 · ExternalCitation · doi-reference

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload

10.1186/1532-429x-12-24 · ExternalCitation · doi-reference

Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

10.1186/1532-429x-12-69 · ExternalCitation · doi-reference

Value of black blood T2∗ cardiovascular magnetic resonance

10.1186/1532-429x-13-21 · ExternalCitation · doi-reference

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

10.1186/1532-429x-13-8 · ExternalCitation · doi-reference

Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance

10.1186/1532-429x-14-42 · ExternalCitation · doi-reference

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major

10.1186/1532-429x-14-8 · ExternalCitation · doi-reference

Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone

10.1186/1532-429x-15-38 · ExternalCitation · doi-reference

Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia

10.1186/s12968-017-0349-3 · ExternalCitation · doi-reference

In vivo calibration of the T2∗ cardiovascular magnetic resonance method at 1.5 T for estimation of cardiac iron in a minipig model of transfusional iron overload

10.1186/s12968-021-00715-6 · ExternalCitation · doi-reference

Society for cardiovascular magnetic resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations

10.1186/s12968-021-00827-z · ExternalCitation · doi-reference

Physiology and pathophysiology of iron cardiomyopathy in thalassemia

10.1196/annals.1345.047 · ExternalCitation · doi-reference

Role of T1 mapping as a complementary tool to T2∗ for non-invasive cardiac iron overload assessment

10.1371/journal.pone.0192890 · ExternalCitation · doi-reference

Deferasirox: pharmacokinetics and clinical experience

10.1517/17425255.2012.640674 · ExternalCitation · doi-reference

A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major

10.2147/dddt.s211630 · ExternalCitation · doi-reference

Emerging understanding of the advantage of small molecules such as hydroxypyridinones in the treatment of iron overload

10.2174/0929867033457629 · ExternalCitation · doi-reference

Electrocardiographic abnormalities in thalassemia patients with heart failure

10.2174/187152909787581345 · ExternalCitation · doi-reference

Heart disease in thalassemia intermedia

10.3109/03630260903351676 · ExternalCitation · doi-reference

Cardiac magnetic resonance imaging R2∗ assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia

10.3324/haematol.10455 · ExternalCitation · doi-reference

Liver iron concentrations and urinary hepcidin in beta-thalassemia

10.3324/haematol.10842 · ExternalCitation · doi-reference

Italian society of hematology practice guidelines for the management of iron overload in thalassemia major and related disorders

10.3324/haematol.12413 · ExternalCitation · doi-reference

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone

10.3324/haematol.2009.009118 · ExternalCitation · doi-reference

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

10.3324/haematol.2009.019042 · ExternalCitation · doi-reference

Continued improvement in myocardial T2∗ over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload

10.3324/haematol.2010.031468 · ExternalCitation · doi-reference

Deferasirox for up to 3 years leads to continued improvement of myocardial T2∗ in patients with beta-thalassemia major

10.3324/haematol.2011.049957 · ExternalCitation · doi-reference

Myocardial Iron in Thalassemia (MINT) Investigators. International survey of T2∗ cardiovascular magnetic resonance in β-thalassemia major

10.3324/haematol.2013.083634 · ExternalCitation · doi-reference

Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications

10.3389/fcvm.2023.1129349 · ExternalCitation · doi-reference